在小麦Guixie 3中的Fusarium头部炎症耐药基因的遗传映射
Yonglu Luo1, Bin Cheng1, Tianqing Chen1
1Guizhou Institute of Upland Crops, Guizhou Academy of Agricultural Sciences, Guiyang, 550006, Guizhou, People's Republic of China.
Journal of applied genetics
|May 15, 2025
概括
研究人员在小麦中确定了15个量化特征位点 (QTLs),用于菌头部炎 (FHB) 耐药性,包括2D.1.染色体上显著的QTL. 这一发现有助于开发FHB耐药的小麦品种.
科学领域:
- 植物病理学 植物病理学
- 农业科学 农业科学
- 遗传学和基因组学 遗传学和基因组学
背景情况:
- 菌头部病 (FHB) 对全球小麦产量构成重大威胁.
- 耐药小麦品种Guixie 3中FHB耐药性的遗传基础尚不清楚.
- 识别新的遗传资源对于培育FHB耐药小麦至关重要.
研究的目的:
- 阐明Guixie中的FHB耐药性的遗传结构 3.
- 识别和绘制与FHB耐药性相关的定量特征位点 (QTLs).
- 为未来的育种应用发现赋予FHB耐药性的候选基因.
主要方法:
- 从Avocet S和Guixie 3之间的交叉中开发了一个F2:7复合同血统 (RIL) 种群.
- 在四个环境 (2年,2个地点) 中,对RIL群体的FHB耐药性进行表型化.
- 利用55K单核酸多态 (SNP) 阵列用于FHB耐药性QTLs的遗传映射.
主要成果:
- 在多个小麦染色体上检测到15个FHB耐药性的QTL.
- 一个主要的QTL,Qfhb.gaas.2D.1-1,在染色体2D.1上一直被确定,解释了显著的表型变异 (14.07-33.00%).
- 在Qfhb.gaas.2D.1-1区域内确定了39个候选基因,其中8个与FHB耐药性有预测的关联.
结论:
- 这项研究成功地绘制了FHB耐药性的多个QTL,提供了有价值的遗传标记.
- 已识别的QTL Qfhb.gaas.2D.1-1代表了在小麦育种中增强FHB耐药性的重要遗传资源.
- 在绘制的QTL区域内的候选基因需要进一步研究它们在FHB耐药机制中的作用.
更多相关视频
08:36Development of Targeting Induced Local Lesions IN Genomes TILLING Populations in Small Grain Crops by Ethyl Methanesulfonate Mutagenesis
Published on: July 16, 2019
11.5K
11:48A Contrast of Three Inoculation Techniques used to Determine the Race of Unknown Fusarium oxysporum f.sp. niveum Isolates
Published on: October 28, 2021
3.2K
相关概念视频
Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
